Why the study?
What is the risk of stent thrombosis in patients with chronic renal insufficiency after percutaneous coronary intervention?
What is the risk of stent thrombosis in patients with chronic renal insufficiency after percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Current literature lacks sufficient data on the incidence and specific management of stent thrombosis in patients with chronic renal insufficiency following PCI.
Renal insufficiency (RI) is a strong predictor of unfavorable outcomes after percutaneous coronary intervention (PCI). After PCI, stent thrombosis (ST) is a considerable concern. The risk of ST in RI has not been independently evaluated before. The mechanism of ST is frequently related to dual antiplatelet underuse. We reviewed the publications listed on Medline, Scopus, and EBSCO Host research database in the last two decades to identify the risk of ST in patients with RI. There are no enough data on the incidence of ST in RI patients. Platelet reactivity, appropriate period of dual antiplatelet therapy, coronary anatomy, selection of stent, and patient compliance are vital issues that warrant detailed evaluation in RI patients. Moreover, prospective trials and new therapeutic strategies are needed for proper assessment and management of ST in high-risk patients.
No takes yet. Share an insight, caveat, or question.
El‐Menyar et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: